Insta
To Boost International Recognition, Govt Planning To Hold Covaxin's Clinical Trials In Bangladesh
Bharat Biotech’s COVAXIN
Looking to boost the recognition of the first Indian indigenously developed COVID-19 vaccine, the Government is planning to facilitate the launch of Covaxin's clinical trials in Bangladesh, reports Hindustan Times.
The Government is already said to have secured the approval to fund the trials in Bangladesh.
The Ministry of External Affairs (MEA) had also recently facilitated the visit of a team of officials from Department of Biotechnology and Bharat Biotech to Dhaka to discuss the proposal with Bangladeshi officials.
Jointly developed by the Hyderabad-based Bharat biotech and Indian Council of Medical Research (ICMR), Covaxin is one of the three vaccines which are actively being used in the country at the moment to inoculate the population against COVID-19.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
